Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa
for
Retinitis Pigmentosa
Location: Boston MA, Minneapolis MN
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT06891885
Phase 1, Phase 2, Recruiting
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Boston MA, Hartford CT, Mineola NY, New York NY,
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT07164443
Phase 3, Recruiting
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
for
Multiple System Atrophy
Location: Boston MA
Sponsor: Tiziana Life Sciences LTD
Sex: All
Age: 30 - 70+
Code: NCT06868628
Phase 2, Recruiting
A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer
for
Triple Negative Breast Cancer (TNBC)
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT07513311
Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
for
Warm Autoimmune Hemolytic Anemia (WAIHA),
Location: Boston MA, Rochester MN, Omaha NE
Sponsor: CRISPR Therapeutics AG
Sex: All
Age: 18+
Code: NCT07549698
Phase 1, Phase 2, Recruiting
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
for
Mantle Cell Lymphoma, Lymphoma
Location: Boston MA, New York NY, St Louis MO
Sponsor: Christine Ryan
Sex: All
Age: 18+
Code: NCT06854003
Phase 2, Recruiting
Glucose Empowerment Through Monitoring and Social Support in Pregnancy
for
Pregnancy, Complications, Gestational Diabetes
Location: Boston MA
Sponsor: Tufts Medical Center
Sex: Female
Age: 18 - 45
Code: NCT07009704
Recruiting
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Boston MA, Westbury NY, Canton OH, Wilson NC,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06899126
Phase 3, Recruiting
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
for
Prostate Cancer (Adenocarcinoma),
Location: Boston MA, New York NY, Philadelphia PA, Madison WI,
Sponsor: Prostate Cancer Clinical Trials Consortium